📦 Regeneron全球领先生物技术制药公司，核心产品Eylea和Dupixent年销售超200亿美元，专注基因工程和抗体开发。
v1.0.02分钟前
0· 41·0 当前·0 累计
by @hanxueyuan下载技能包
最后更新
2026/4/22
安全扫描
OpenClaw
安全
high confidenceThis is a self-contained informational skill about Regeneron (company profile) that requests no credentials, does not install anything, and contains only static content — its requirements align with its description.
评估建议
This skill is an offline, informational profile about Regeneron and is internally consistent with that purpose. Remaining considerations: (1) the source is 'unknown' — verify facts (financials, dates, market-share figures) against primary sources before using them for decisions; (2) because it contains static prose, it cannot perform actions or access your system — there is low technical risk; (3) if you need up-to-date or authoritative regulatory/clinical data, consult official filings, company...详细分析 ▾
✓ 用途与能力
The skill's name and description claim to provide background and analysis on Regeneron; the skill is instruction-only and contains only company info. It requests no binaries, env vars, or config paths, which is proportionate for an informational/company-profile skill.
✓ 指令范围
SKILL.md is a static company profile with 'read_when' contexts that match its stated use cases (queries about Regeneron, market/competitive analysis, investment prep). It does not instruct the agent to read user files, access unrelated environment variables, call external endpoints, or transmit data.
✓ 安装机制
No install spec and no code files are present; nothing will be written to disk or downloaded during install. This is the lowest-risk installation model.
✓ 凭证需求
The skill declares no required environment variables, no credentials, and no config paths. No secret access is requested or implied by the content.
✓ 持久化与权限
always:false and default invocation settings are used. The skill does not request permanent or elevated presence and does not modify other skills or system-wide settings.
安全有层次，运行前请审查代码。
运行时依赖
无特殊依赖
版本
latestv1.0.02026/4/22
Regeneron skill v1.0.0 changelog - 提供再生元制药（Regeneron）公司详细介绍及历史发展里程碑 - 解析公司核心业务、主要产品（Eylea、Dupixent）及市场地位 - 展示VelocImmune等技术平台和与赛诺菲的战略合作优势 - 汇总关键财务与业务数据，概述研发管线和市场份额 - 增补值得了解的趣味/行业见解，方便投资分析及竞品对比
● 无害
安装命令
点击复制官方npx clawhub@latest install regeneron
镜像加速npx clawhub@latest install regeneron --registry https://cn.longxiaskill.com镜像同步中